what’s new in pediatric ophthalmology presentation.pdfwhat’s new in pediatric ophthalmology...
TRANSCRIPT
What’s New in Pediatric Ophthalmology
Forrest J Ellis MD Northern Virginia Ophthalmology Associates
Falls Church, Fairfax, Alexandria (Milan, Paris, Singapore, London)
What’s New
• Myopia treatment • Retinopathy of Prematurity • Vision Screening • Genetics of Strabismus
Myopia
Myopia
• Most common eye problem worldwide – 20% of world population – 10% of US school age Children
• Asians> Hispanics> Caucasians and African Americans
– 77% of High school children in China
• 99% of current South Korean high school graduates
Why do we care?
• Lifetime increased risks – Cataract – Glaucoma – Retinal detachment – Macular degeneration
• Costs – $125 per myopic child per year direct costs – $90 per capita for all eye disease per year – US $10 billion per year on myopia
Myopia – risk factors
• Genetics • Environmental (no strong correlation)
– Near work – Computer games
• Environmental (positive correlation) – Urbanization – associated with increasing rates of
myopia – Higher IQ – Time spent indoors (not spent outdoors)
Myopia – Associated Disorders
Ocular Disease Congenital Glaucoma ROP RP Cataract CSNB Keratoconus Aland eye disease Gyrate Atropy Pseudomyopia Albinism
Multi-system disease Sticklers Syndrome Diabetes Mellitus (uncontrolled) Marfan Weill-Marchesani Knobloch Ehlers Danlos
Myopia - Treatment
• Glasses • Contact Lenses • Refractive Surgery
What if glasses invented after Lasik?
• “Amazing new device eliminates need for millions to undergo expensive eye procedure”
Myopia progression management
• Atropine topical eye drops • Orthokeratology • Bifocals • Specialty fit contact lenses
– Peripheral optical blur
Atropine Trials for Myopia control ATOM 1
• Atropine 1% ophthalmic – Nonspecific muscarinic acetylcholine receptor
antagonist – Atropine 1% each eye at bedtime
• ATOM 1 (1994-2004) – 77% REDUCTION IN PROGRESSION OF MYOPIA
• Significant rebound once treatment discontinued • Side effects
– Pupil dilation – Paralysis of near focus
ATOM 2
• Lower dose atropine (2 year study) – 0.5%, 0.1%, 0.01% – All clinically similar results – 0.01% atropine drop
• No pupil dilation • No near defocus • No rebound effect when discontinued • No cases of allergic or chemical conjunctivitis
• Atropine decreased myopic progression and axial length elongation by >50%
ATOM 1 and 2
Alternative treatments
• Orthokeratology (ortho-K) (CRT) – Contact lens worn at night to reshape cornea – Effect lasts about 3 days
• Ortho-K to prevent myopia progression – Limited long term studies – Similar results to treatment with glasses and
Atropine 0.01% – Risks include bacterial keratitis
Recommendations to prevent or slow down Myopia
• Increase time outdoors • Atropine 0.01% each eye at bedtime
– Probably can stop after puberty
• Full myopic power correction – No evidence that glasses or contacts increase rate
of myopia correction
• Bifocals – Small effect
Retinopathy of Prematurity
Retinopathy of Prematurity
• Disease of the retina of premature infants • Risk factors
– Lower birth weight – Lower gestational age – Many additional risk factors
• Caused by disorganized blood vessel growth in the developing infant eye.
ROP – laser treatment
ROP – Zone 1
Advanced ROP
Bevacizumab (Avastin) for ROP • BEAT ROP
– Bevacizumab (Avastin) vs Laser in ROP. – Prospective, controlled, randomized, stratified, multicenter
trial – Intravitreal bevacizumab monotherapy for zone I or zone II
posterior stage 3 ROP with plus disease. – Avastin showed a significant benefit for zone I but not zone
II disease. – Development of peripheral retinal vessels continued
(recurs) after treatment with intravitreal bevacizumab – Conventional laser therapy led to permanent destruction
of the peripheral retina. • Safety issues regarding Avastin in ROP not assessed.
Bevacizumab (Avastin) for ROP
• VEGF levels reduced in serum following VEGF intravitreal injection
• Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity. Pediatrics. 2016 Apr;137(4). pii: e20153218. doi: 10.1542/peds.2015-3218. Epub 2016 Mar 17. – Preterm infants treated with bevacizumab versus
laser had higher (3.1x) odds of severe neurodevelopmental disabilities.
Current Therapy of ROP at INOVA
• Laser Treatment for Zone 2 ROP – Zone II, stage 2-3 with plus disease
• Avastin for ROP in Zone 1 – Zone I, any stage with plus disease – Zone I, stage 3 without plus disease
• Rescue therapy with laser if ROP recurs following avastin treatment
Vision Screening
Vision Screening
• Emerging technologies – Instrument based visual screening
• Photo screening • Autorefraction • Birefringent retinal screening
Age Tests Referral Criteria Comments
Newborn to 12 months
•Ocular history •Vision assessment •External inspection of the eyes and lids •Ocular motility assessment •Pupil examination •Red reflex examination
•Refer infants who do not track well after 3 months of age. •Refer infants with an abnormal red reflex or history of retinoblastoma in a parent or sibling.
12 to 36 months
•Ocular history •Vision assessment •External inspection of the eyes and lids •Ocular motility assessment •Pupil examination •Red reflex examination •Visual acuity testing •Objective screening device “photoscreening” •Ophthalmoscopy
•Refer infants with strabismus •Refer infants with chronic tearing or discharge. •Refer children who fail photoscreening.
36 months to 5 years
•Ocular History •Vision assessment •External inspection of the eyes and lids •Ocular motility assessment •Pupil examination •Red reflex examination •Visual acuity testing (preferred) or photoscreening •Ophthalmoscopy
Visual acuity thresholds •Ages 36-47 months: Must correctly identify the majority of the optotypes on the 20/50 line to pass. •Ages 48-59 months: Must correctly identify the majority of the optotypes on the 20/40 line to pass. •Refer children who fail photoscreening.
5 years and older* *Repeat screening every 1-2 years after age 5.
•Ocular history •Vision assessment •External inspection of the eyes and lids •Ocular motility assessment •Pupil examination •Red reflex examination •Visual acuity testing •Ophthalmoscopy
•Refer children who cannot read at least 20/32 with either eye. Must be able to identify the majority of the optotypes on the 20/32 line. •Refer children not reading at grade level.
Related
Why screen?
• Amblyopia 2-4% of children • Etiology
– Unequal refractive error – Strabismus – Less common
• Cataract, corneal abnormalities, ptosis, etc
Vision screening
• Visual acuity testing in office difficult – Children less than 3 years – Developmental delays
• Important to detect amblyopia early • Assess amblyopia risk factors
Amblyopia risk factors
• Strabismus • Astigmatism • Unequal refractive errors • High hyperopia (bilateral) • High myopia (bilateral) • Media opacities
Instrument based vision screening
• AAPOS guidelines for referral for photoscreening should have a high specificity and sensitivity
• Depending on age – Astigmatism >1.5-2.0 diopters – Hyperopia >3.5-4.5 diopters – Myopia > 1.5- 3.5 diopters – Inter-eye difference (anisometropia) >1.5-3.5 diopters – Media opacity greater than 1mm – Strabismus (greater than 8 prism diopters)
Photoscreening devices
• Plusoptix
– Measures pupil size – Corneal reflexes – Refraction – 92% sensitivity – 88% specificity
Photoscreening devices
• Spot vision screener – Similar feel to camera – Refraction – Pupil size – Automated computer analysis
Photoscreening devices
• iScreen • Mobile apps
– GoCheck Kids • No upfront costs to
download app • In app pricing model • Similar to other devices in
accuracy
Retinal Scanning
• Rebiscan – Even minimal amblyopia results in micro-
strabismus – Measures exact foveal fixation using retinal
birefringence and laser scanning – Very high sensitivity and specificity – Recently obtained FDA approval – Not yet commercially available
Rebiscan
Rebiscan
Genetics of Strabismus
Mis-innervation / Dysinnervation
• Congenital fibrosis of the extraocular muscles – Types 1,2,3, and Tukel syndrome
• Duane syndrome • Moebius syndrome • Horizontal gaze palsy with progressive
scoliosis • Synergistic divergence
Mis-innervation / Dysinnervation
• Congenital ptosis • Jaw-wink ptosis • Congenital superior oblique paresis • Brown syndrome
Mis-innervation Mechanism
• What happens when the nerve fails to develop – The innervated muscle does not develop – The opposing extraocular muscles develop
unopposed and appear contractured and fibrotic
Congenital cranial dysinnervation disorders
• Known genetic abnormalities • Duane syndrome
– CHN1 gene • DURS2 locus (autosomal dominant)
– DURS1 locus (chromosome 8q13) • Simplex cases
• Horizontal gaze palsy with progressive scoliosis – ROBO3 gene
• Congenital ptosis – Locus on chromosome 1p
• Jaw –wink ptosis – A patient with Duane syndrome and Marcus Gunn Jaw-wink has been
reported – KIF21A mutation reported in a patient with MG ptosis and CFEOM
• Congenital fibrosis of the extraocular muscles
Duane syndrome • SALL4- related disorders
– Okihiro, Duane radial ray, acro-renal-ocular syndrome, IVAC syndrome – Unilateral or bilateral Duane syndrome with radial ray abnormalities
• SALL1-related disorders – Duane syndrome and renal anal, limb and ear deformities
• HoXA1 related syndromes – Duane syndrome and bilateral senorineural hearing loss and
craniofacial maldevelopment • Wildervank syndrome
– Duane syndrome, deafness, Klippel-Feil anomaly • Goldenhar syndrome
– Hemifacial microsomia. Oculoauriculovertebral, Duane syndrome
Duane syndrome
• What happens when the nerve fails to develop – In Duane syndrome the 6th nerve nucleus is
typically absent – However, a branch of the 3rd nerve innervates the
lateral rectus – As a result the lateral rectus develops as a normal
muscle, but just contracts at the wrong time
Unusual associations
Duane with severe leash?
Duane with severe leash? (or SR mis-innervation)
Congenital ptosis
• Congenital ptosis – Genetically identified abnormality (1p)
• PTOS1 locus
– Often associated with other syndromes or abnormalities of the EOMs
– Unilateral, bilateral, or asymmetric – Often a family history
Congenital ptosis
Unusual associations
• Left ptosis with Left infraduction deficit
Marcus Gunn jaw wink ptosis
• What happens when the nerve fails to develop – Marcus-Gunn Jaw-wink ptosis – The nerve to the levator palpebrae superioris fails to
develop – Unlike congenital ptosis, the levator muscle appears
fairly normal because it is innervated a branch of the trigeminal nerve (usually the branch to the lateral pterygoid muscle)
• Rare familial cases have been reported • KIF21A mutation reported in a patient with MG ptosis and
CFEOM
Marcus Gunn jaw wink ptosis
What about congenital superior oblique paresis
• MRI evidence of hypoplastic development or absence of the 4th nerve/nucleus
• Hypoplasia of the SO muscle • Occasionally familial
Congenital superior oblique paresis
• Left so paresis mom • Right SO paresis in daughter
Bilateral Brown syndrome
Left Duane syndrome
Left Duane syndrome
Unusual associations
Fresnel prism
• Film used to correct double vision • Kind of new
Fresnel prism
Fresnel prism
Thank You